Where is the live CopyMark page for USPTO serial 97492928?

The live record is at https://getcopymark.com/trademark/97492928. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

What is the current status of RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE?

RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE (97492928) currently shows USPTO status code 622 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE?

The public record lists International Classes: 005, 010. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE Serial# 97492928 | status 622; last event NWAP | Trademark Info & Attorney Guidance

Q: Who owns RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE?

According to the public USPTO record for serial number 97492928, the listed owner(s) include: Glenmark Specialty S.A..

Q: What is USPTO serial number 97492928?

Serial number 97492928 is the USPTO application identifier for the mark RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE. It is used to track examination, publication, and registration of this trademark.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Glenmark Specialty S.A.
Neuchâtel, CH
Other trademarks owned by Glenmark Specialty S.A.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maxim A. Voltchenko

MAXIM A. VOLTCHENKO KAPLAN BREYER SCHWARZ, LLP90 MATAWAN ROAD - SUITE 201MATAWAN, NJ 07747UNITED STATES

Goods and services

Class	Description	Status	First use
005	Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled	ACTIVE	—
010	Antihistamine delivery device sold empty; nasal steroid delivery device sold empty; nasal spray preparation delivery device sold empty	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jul 11, 2022	NWAP	NEW APPLICATION ENTERED	—

RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE